HENLIUS
Live / Applied — Second extension granted (statement of use) (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 19 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98230723
- Mark type
- Design + words
- Filed
- 19 Oct 2023
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Lawrence J. Crain
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; pharmaceutical preparations for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; drugs for medical purposes in the nature of pharmaceutical preparations for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; vaccines; Capsules sold empty for medicines; biological preparations for medical purposes for the treatment of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; diagnostic preparations for medical purposes; wadding for medical purposes; chemical preparations for medical purposes, namely, for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases
- Class 042 — Scientific and technological services: Scientific laboratory services; scientific research; Technological research in the field of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; conducting technical project studies in the field of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; quality control for others; medical research; research and development of new products for others; biological research; chemical research; Scientific research in the nature of conducting clinical trials for others; material testing; chemistry services in the nature of research in the field of chemistry; industrial design; design of interior decor; dress designing; software as a service (SAAS) services featuring software for development of drug research methods; computer software design; interior design
- Class 044 — Medical, beauty and agricultural services: Medical clinic services; pharmacy advice in the nature of medication counseling; therapy services, namely, drug regimen design; rest home services; dietary and nutritional advice; beauty salon services; rental of sanitary installations; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; telemedicine services
Owner
- Shanghai Henlius Biotech, Inc., Shanghai, CN
- Shanghai Henlius Biotech, Inc., Shanghai, CN
Prosecution history
- 05 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2025 — SOU EXTENSION 2 GRANTED
- 04 Nov 2025 — SOU EXTENSION 2 FILED
- 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2025 — SOU EXTENSION 1 GRANTED
- 29 Apr 2025 — SOU EXTENSION 1 FILED
- 29 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 12 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED